Clinical Trials Logo

Clinical Trial Summary

The main purpose of this study is to validate the ability of the Nelli system (video-based epilepsy examination system) to detect epileptic motor seizure behaviors in patients at rest.


Clinical Trial Description

Proper seizure documentation is an important tool to evaluate treatment outcomes and risks associated with epileptic seizures. Apart from a costly in-hospital video electro-encephalogram (VEEG) monitoring, most patients with epilepsy log and track their seizures with the help of the seizure diaries only. However, the reliability of the diaries is heavily dependent on an accurate recognition and recording of the seizures. There is an obvious need for a more objective and reliable seizure detection method. The investigators propose a low-cost video-based examination system, designed to detect motor seizure behaviors in patients at rest. The main aim of this study is to clinically validate the ability of the Nelli system (video-based epilepsy examination system) to detect epileptic motor seizure behaviors in patients at rest, using simultaneous VEEG as the ground truth with the reference to all motor seizures and individual motor seizure types. Study design established as follows: 1. Study population is represented by 90 epilepsy patients with suspected history of motor seizures undergoing a standard VEEG examination for clinical evaluation of epilepsy. 2. Co-registration of standard VEEG with the Nelli video- and audio-based system is performed, duration of the registration is 1-4 days. 3. The inclusion criteria for seizures: 1. Epileptic motor seizures appearing from rest while patients are in supine position in their monitoring bed. 2. The seizures are determined to be epileptic based on electroclinical characteristics by the responsible neurophysiologist / epileptologist. 3. The seizures can be classified into motor seizure types (both focal and generalized) using the 2017 International League Against Epilepsy (ILAE) seizure classification. 4. The registrations are analyzed by the Nelli system blinded to any clinical information. Nelli system consists of two evaluation components: 1. Algorithmic component (pre-trained machine learning model based on video and audio signals) 2. Supervisory component (performed by experienced VEEG technicians) 5. Reports containing the seizure type classification (time-stamped) are provided by the VEEG laboratory, the performance of the Nelli system is assessed using these reports as the ground truth. a. Specificity and sensitivity of the Nelli system are evaluated with reference to both all motor seizures and individual motor seizure types. 6. The secondary outcome measures are established as follows: 1. To assess the latency from the onset of the seizure detection by the Nelli system in comparison to VEEG registration. 2. To determine an inter-rater agreement for the supervisory component of the Nelli system. 3. To investigate the performance of the algorithmic component of the Nelli system alone. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04171934
Study type Observational [Patient Registry]
Source Tampere University
Contact
Status Completed
Phase
Start date June 17, 2019
Completion date December 15, 2021

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03548779 - North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2 N/A
Completed NCT05605301 - Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy Phase 2
Completed NCT05257811 - Earbud EEG Feasibility Study
Completed NCT05066880 - Yoga and Aerobic Exercise in Epilepsy N/A
Recruiting NCT06278428 - Genotype, Phenotype, and Disease Progression of Developmental Epileptic Encephalopathy With Onset Before 2 Years of Age
Terminated NCT04639310 - XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy Phase 3
Withdrawn NCT04737174 - ES-481 for Uncontrolled Glioma-Associated Epilepsy and Assessment for Potential Anti-Tumorigenic Effect in Patients With Isocitrate Dehydrogenase 1 (IDH1) Mutant Tumors Phase 2
Not yet recruiting NCT06275685 - Forecasting Seizures Using Intelligent Wearable Technology for Health Tracking N/A
Completed NCT04822662 - The Individual and Family Self Management Theory Based Epilepsy Education Program's Effectiveness N/A
Recruiting NCT04759196 - Generating Evidence on NonEpileptic, Stereotypical and Intermittent Symptoms (NESIS) in Chronic Subdural Hematomas Phase 4
Recruiting NCT04569708 - Sleep Spindles and Memory in Rolandic Epilepsy N/A
Completed NCT04311151 - Impact of Self-visualization of Epileptic Seizures on Patients' Perception of the Disease and Risk Behavior N/A
Not yet recruiting NCT05635396 - Seizures Detection in Real Life Setting N/A
Completed NCT05675254 - The Prevalence and Risk Factors of Coagulopathy in Pediatric Epilepsy Surgery Patients
Terminated NCT04912856 - An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEE Phase 3
Recruiting NCT04221282 - ZEBinix® Retention Rate in Epilepsy in Elderly Patients